Carregant...
Gene expression identifies heterogeneity of metastatic behavior among gastrointestinal stromal tumors
BACKGROUND: Adjuvant imatinib is useful in patients with gastrointestinal stromal tumors (GIST) at high risk of recurrence. At present, the risk of recurrence is determined based on tumor size, mitotic rate, tumor site, and tumor rupture. Previous studies using various biochemical pathways identifie...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4752787/ https://ncbi.nlm.nih.gov/pubmed/26873324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-0802-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|